The treasurer’s attitude carries a distinct “let them eat cake” arrogance towards the difficult financial realities facing many ordinary taxpayers. Anthropic’s Mythos in the wrong hands would be ...
It was the fourth such deal struck by the administration to get companies to forfeit their offshore wind leases. By Maxine Joselow Thousands of acres in Utah and other Western states have burned. Here ...
Temporal Co-founder and CEO Samar Abbas weighs in on AI reliability, execution and what IT decision-makers should to keep in mind as agentic AI tools become ever more ubiquitous. The company says the ...
Health news moves fast, with new studies, findings, and regulatory updates changing the landscape daily. Insights from advocates and celebrities can also impact the public awareness of certain health ...
Cisco's new certs are a wake-up call for AI-era network engineers Cisco’s revamped CCNA and CCIE certifications are a skills blueprint for AI-era networking, where automation, observability, and human ...
June 30, 2026 • Mark Zuckerberg met with Kalshi's CEO last year about a potential deal, but talks did not move forward. Now Meta is making its own prediction market app. June 30, 2026 • The Ebola ...
New! Sign up for our free email newsletter.
The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors and ...
4 things that need to change about gen-AI Generative AI isn’t going away, that’s for sure. But that doesn’t mean we have to live with the most dangerous and problematic aspects of gen-AI. Here’s four ...
June 30, 2026 • As the Supreme Court today weighs the Trump administration's effort to revoke birthright citizenship, NPR looks at what else the White House has done to curb illegal and legal ...
Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors.
Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it.